VEGFA and retinopathy of prematurity: Ischemic proliferative retinopathies, such as retinopathy of prematurity (ROP) and diabetic retinopathy (DR), remain a major threat to vision despite major advances in the treatment of late neovascular complications by anti-VEGF therapies [1–3].